Colonial Trust Advisors’s Biogen BIIB Stock Holding History

Colonial Trust Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.67K	Hold	20	–	–	﹤0.01%	627
2025 Q4	$3.52K	Hold	20	–	–	﹤0.01%	612
2025 Q3	$2.8K	Hold	20	–	–	﹤0.01%	609
2025 Q2	$2.51K	Buy	+20	New	+$2.49K	﹤0.01%	630
2024 Q1	–	Sell	-4	Closed	-$1.03K	–	1029
2023 Q4	$1.03K	Hold	4	–	–	﹤0.01%	768
2023 Q3	$1.03K	Hold	4	–	–	﹤0.01%	772
2023 Q2	$1.14K	Hold	4	–	–	﹤0.01%	787
2023 Q1	$1.11K	Sell	4 -1	-20%	-$277	﹤0.01%	785
2022 Q4	$1.39K	Buy	+5	New	+$1.41K	﹤0.01%	767

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Colonial Trust Advisors's BIIB Position: Q1 2026 in Review

Colonial Trust Advisors held its Biogen (BIIB) position steady in Q1 2026 at 20 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Colonial Trust Advisors first reported a position in BIIB in Q4 2022 and has held it in 9 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Colonial Trust Advisors held 20 shares of Biogen worth $3.67K as of Q1 2026.
Colonial Trust Advisors left its Biogen share count unchanged in Q1 2026.
Biogen made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #627 holding.
Colonial Trust Advisors first reported a position in Biogen in Q4 2022 and has held it in 9 quarters since.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.